Search Results - "Morton, JP"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Assessment of vitamin D concentration in non-supplemented professional athletes and healthy adults during the winter months in the UK: implications for skeletal muscle function by Close, G.L., Russell, J., Cobley, J.N., Owens, D.J., Wilson, G., Gregson, W., Fraser, W.D., Morton, J.P.

    Published in Journal of sports sciences (01-02-2013)
    “…The current study implemented a two-part design to (1) assess the vitamin D concentration of a large cohort of non-vitamin D supplemented UK-based athletes and…”
    Get full text
    Journal Article
  2. 2

    Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis by Arjonen, Antti, Kaukonen, Riina, Mattila, Elina, Rouhi, Pegah, Högnäs, Gunilla, Sihto, Harri, Miller, Bryan W, Morton, Jennifer P, Bucher, Elmar, Taimen, Pekka, Virtakoivu, Reetta, Cao, Yihai, Sansom, Owen J, Joensuu, Heikki, Ivaska, Johanna

    Published in The Journal of clinical investigation (01-03-2014)
    “…Mutations of the tumor suppressor TP53 are present in many forms of human cancer and are associated with increased tumor cell invasion and metastasis. Several…”
    Get full text
    Journal Article
  3. 3

    Centrifuge modelling of an instrumented free-fall sphere for measurement of undrained strength in fine-grained soils by Morton, J.P, O’Loughlin, C.D, White, D.J

    Published in Canadian geotechnical journal (01-06-2016)
    “…This paper describes centrifuge tests in which a model free-fall sphere was allowed to free fall in water before dynamically embedding within reconstituted…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Functions of TAp63 and p53 in restraining the development of metastatic cancer by Tan, E H, Morton, J P, Timpson, P, Tucci, P, Melino, G, Flores, E R, Sansom, O J, Vousden, K H, Muller, P A J

    Published in Oncogene (19-06-2014)
    “…Many tumours harbour mutations in the p53 tumour-suppressor gene that result in the expression of a mutant p53 protein. This mutant p53 protein has, in most…”
    Get full text
    Journal Article
  6. 6

    The effects of intermittent hypoxic training on aerobic and anaerobic performance by Morton, James Peter, Cable, Nigel Tim

    Published in Ergonomics (15-09-2005)
    “…The aim of the present study was to determine whether short-term intermittent hypoxic training would enhance sea level aerobic and anaerobic performance over…”
    Get full text
    Journal Article
  7. 7

    The relationship between physical match performance and 48-h post-game creatine kinase concentrations in English Premier League soccer players by Scott, A, Malone, JJ, Morgans, R, Burgess, D, Gregson, W, Morton, JP, Drust, B

    “…The aim of the investigation was to determine the relationship between blood creatine kinase and physical match performance in 15 elite male soccer players…”
    Get full text
    Journal Article
  8. 8

    p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB by Johnson, Deborah L, Crighton, Diane, Woiwode, Annette, Zhang, Cheng, Mandavia, Nihar, Morton, Jennifer P, Warnock, Lorna J, Milner, Jo, White, Robert J

    Published in The EMBO journal (02-06-2003)
    “…The tumor suppressor p53 is a transcription factor that controls cellular growth and proliferation. p53 targets include RNA polymerase (pol) III‐dependent…”
    Get full text
    Journal Article
  9. 9

    Reliability of maximal muscle force and voluntary activation as markers of exercise-induced muscle damage by Morton, James Peter, Atkinson, Greg, MacLaren, Donald Pm, Cable, Nigel Tim, Gilbert, Gareth, Broome, Caroline, McArdle, Anne, Drust, Barry

    Published in European journal of applied physiology (01-08-2005)
    “…The loss of the ability of skeletal muscle to generate force is one of the most appropriate and valid means to quantify muscle damage. Routine measurements of…”
    Get full text
    Journal Article
  10. 10

    mTOR signaling is a promising therapeutic target in a subset of human pancreatic ductal adenocarcinomas by Morran, D.C, Karim, S.A, Jamieson, N.B, McKay, C.J, Carter, R, Evans, T.R.J, Sansom, O.J, Morton, J.P

    “…Category: Malignant Purpose: Human pancreatic ductal adenocarcinoma (PDAC) remains an intractable disease with little change in 5 year survival over the past…”
    Get full text
    Journal Article
  11. 11

    CXCR2 inhibition protects against chronic pancreatitis in a murine model by Steele, C.W, Morton, J.P, McKay, C.J, Evans, T.R.J, Carter, C.R, Sansom, O.J

    “…To examine the importance of neutrophils in this process we used a neutrophil blocking antibody and found that there was significant pancreatic damage from…”
    Get full text
    Journal Article
  12. 12

    Microbial reduction of Fe(III) in the Fithian and Muloorina illites; contrasting extents and rates of bioreduction by Seabaugh, Jennifer L, Dong, Hailiang, Eberl, Dennis D, Morton, John P, Kim, Jinwook

    Published in Clays and clay minerals (01-02-2006)
    “…Shewanella putrefaciens CN32 reduces Fe(III) within two illites which have different properties: the Fithian bulk fraction and the <0.2 µm fraction of…”
    Get full text
    Journal Article
  13. 13

    Deregulation of RNA polymerase III transcription in cervical epithelium in response to high-risk human papillomavirus by DALY, Nicole L, ARVANITIS, Demetrios A, FAIRLEY, Jennifer A, GOMEZ-ROMAN, Natividad, MORTON, Jennifer P, GRAHAM, Sheila V, SPANDIDOS, Demetrios A, WHITE, Robert J

    Published in Oncogene (27-01-2005)
    “…RNA polymerase (pol) III transcription is a major determinant of biosynthetic capacity, providing essential products such as tRNA and 5S rRNA. It is controlled…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Clinical Results of Entrance Dose In Vivo Dosimetry for High Energy Photons in External Beam Radiotherapy Using MOSFETs by Morton, J P, Bhat, M, Williams, T, Kovendy, A

    “…Thomson and Nielsen TN-502 RD MOSFETs were used for entrance dose in vivo dosimetry for 6 and 10 MV photons. A total of 24 patients were tested, 10 breast, 8…”
    Get full text
    Journal Article
  18. 18

    Evaluation of MOSFETs for Entrance Dose Dosimetry for 6 and 10 MV Photons with a Custom Made Build Up Cap by Morton, J P, Bhat, M, Kovendy, A, Williams, T

    “…Commercially available MOSFETs, Thomson and Nielsen TN502-RD, were evaluated for suitability as an entrance dose in vivo dosimeter for 6MV and 10MV. Detector…”
    Get full text
    Journal Article
  19. 19

    A Comparison of Two Patient-friendly ERG Electrodes by Hidajat, R R, McLay, J L, Elder, M J, Goode, D H, Morton, J P, Burley, C D

    “…The ideal electroretinography (ERG) electrode does not exist. In deciding which electrode should be used in clinical practice the capacity to provide…”
    Get full text
    Journal Article